Emmanuel J Favaloro Shares Yet Another Paper from The 100th Anniversary of VWD
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared on LinkedIn:
”100 years of von Willebrand disease (VWD).
2026 marks the 100th year anniversary of the initial publication of the bleeding disorder ‘pseudo-hemophilia’ that later became known as VWD.
Seminars in Thrombosis and Hemostasis will publish several papers on VWD in 2026.
This is the third one in queue – on VWD therapy – pdVWF vs rVWF concentrate.
Enjoy!”
Read the full article here.
Article: Vonicog Alfa versus Plasma-Derived von Willebrand Factor During Hospitalization: Results of an Observational Retrospective Multicenter Study
Authors: Valérie Horvais, Catherine Ternisien, Julien Denis-Le-Sève, Philippe Beurrier, Marc Fouassier, Antoine Babuty, Nicolas Drillaud, Brigitte Pan-Petesch, Johann Rose, Vincent Cussac, Sophie Bayart, Benoît Guillet, Marc Trossaërt
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 28, 2026, 12:56Sinju Thomas: Presenting Gene Therapy Collection Challenges at the Apheresis Hub Conference 2026
-
Feb 28, 2026, 12:54Mahesan Subramaniam: Supporting Circulation and Managing Cholesterol Protects Heart and Brain
-
Feb 28, 2026, 12:09Gonzalo Montero Martin: A Breakthrough in HLA Nomenclature for Transplant Evaluation
-
Feb 28, 2026, 11:47Abdul Mannan: Paradox of Bleeding and Clotting in Uremic Coagulopathy
-
Feb 28, 2026, 11:40Jim Hoffman: Could Extracorporeal Removal of NETs Become a ‘Holy Grail’ Therapy Across Multiple Diseases?
-
Feb 27, 2026, 18:30Sanjeev Saksena: From Isolated Case Reports to Clinical Evidence for Post-Ablation Myocardial Ischemia
-
Feb 27, 2026, 18:21Priya Prasad: Can Money Buy Blood?
-
Feb 27, 2026, 18:19Trulee Cardona: Hemophilia Care in Uzbekistan and Why It Matters
-
Feb 27, 2026, 18:19Bartosz Hudzik: Do Elevated Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Otherwise Healthy Women?